Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well I’m long for many years so yo figure it out.
Next up TLD. Then we’ll see where all the parts of the puzzle fall in place.
Most likely anytime next 2 weeks. It was an estimate so it could take longer IMO.
Like a volcano buildup up pressure over the weekend., watch Mt. St Helens explode, this maybe more like Yellow Stone, a super volcano.
Maybe Gilead or the like has indicated a possible move on BO or partner if results are good.
New stock options to for directors of a million shares each. This is the kind of thing that is done ahead of a possible buyout, including Leo’s new employment agreement.
Mid October coming up. Can someone please tur off the spell checker on this board, the corrections it makes are ten fold the errors it try’s to correct.
They corrected it after it was pointed out that they had it wrong.
Because they didn’t pay to play.
CVAC shelves CV vaccine. Another one bites the dust.
Their not breaking ranks. Mako Lives!!! Mako’s research said the Gatling gun is junk science so line up and hold the line. BTW wonder if Mako ever got another job versus the reported Applebee’s job in the Dallas Fort area?
Q4 just started, no news is no news. At least you are consistent in your reasoning if that’s what you want to call it.
Replying within 10 days is too late. 10 days certainly. I’m not clear what level of requests can be fulfilled , since B is not manufactured in any significant way at this point.
That’s what I thought. They must get the approval before B TLD. FDA gets some Board and/or executive positions in the future. Leo was probably told we cannot upstage Merck’s antiviral, so report mid to late October. After all they paid to play. Maybe that was the FDA’s / BPs plan to give Merck and PFE the mild to moderate space, now looking like just mild. And give B the moderate to severe patients, since there is nothing BP has for that space , so pay to play is waived if Leo stays in his lane.
That’s is exactly what I meant. You said it much better than I could. I’m at a airport getting to my terminal. Just don’t have time to elaborated to LR’s standard.
The difficulty of mass production , variant obsolescence, expensive to produce, we have a whole world that needs it, not just the US.
Procurement funds is a better use of wording.
Merck making a move to abscond with the EUA funds. What’s the emergency to rush a treatment that has potentially very harmful side effects. Whose efficacy for moderate CV patients failed. India trials said it failed for mild as well. What’s the emergency need?
It would be hard to imagine you could determine any AE’s associated to B after one day. Severe CV patients at that stage water could be associated with AE’s. Most likely it’s everything and Rem that is thrown at them.
Ever get a response?
Mid to late October probably starts 10/18 IMO. I’d love it if Leo was giving a conservative estimate. Not expecting any next week.
Well not until Covid. Someone may make a case .
If IPIX wasn’t smeared by Mako and the likes probably paid by MM’s to write the articles, IPIX would be in a position to have B already approved for use for CV, at the time Rem was approved. If B shows to be effective. How many lives would that have saved? Another way of saying it is how many lives did the MM’s, and Makos kill. All Makos B’s negative analysis, the basis for the Rosen lawsuit,?were thoroughly eviscerated point by point in the trial. There is will be hell to pay!!!
Went up that amount
This is really weird. One of my accounts that has IPIX , IPIX went up $6,666.60. Now the Sadhguru, says numbers that show up in a pattern or certain sequence means something significant is going to happen, game changing. The stronger the pattern the more significant the event/change will be. Just thought I’d share because it just seems very bizarre.
They must not break the ranks and hold the SP. Although the military not breaking ranks or the line went back to the Romans, it ended with Jordan Gatling inventing the Gatling gun, which could just mowed down the entire line of soldiers. Much like the soldiers in 1861, the shorts are about to get mowed down. Yet they don’t know it because they believe in Mako, MAKO LIVES!!!!…lol!
The scale then would only be for CV for the licensing deal and wouldn’t be for anything else. License one treatment for one ailment at a time.
The way vaccines are losing effectiveness quickly, breakthrough cases (who knows what %), treatments / antivirals whose side effects are beyond horrible… I sure hope B is effective, I don’t care about making millions, I am worried for the human race. It is possible B may end up being the only solution to Covid. IMO
I’ll be adding. Now that there is no competition in the moderate to severe cases. Merck’s antiviral looks like a loser. PFE’s results next for mild cases of CV. The only concern I have is the makeup of severe versus moderate cases of the trial. We know B’s antiviral has a superior SI score. I think the load on B patients moderate to severe will be on the other 2 treatment properties of its 3 in 1 treatment. IMO
The potential side effects are too great for the the FDA to give full approval IMO. Shouldn’t approve it at all. The labeling should be very restrictive. I mean Merck should know better, have more morals then trying to grab the Government $$$, and push this as a treatment for $$$ with those potential side effects to make a buck. But they paid to play, so look for approval and watch the FDA go after other drugs with only a potential possible AE to show they are about safety.
Well the Merck antiviral pump is hurting PFE, and Moderna too. Although if anyone really understood the possible side effects, no way in heck would you take it. Maybe it’s really for population control…lol
What if the world all popped a B pill at the same time. May cure a lot of maladies at the same time.
Only BP can put lipstick on a pig and make it look beautiful. FDA of course gives the nod. It’s about pay-to-play. Of course they will get $$$ approved by the government and suck that funding source dry.
It’s been a process of elimination of competing therapeutics and even the vaccines which look like substandard treatments versus vaccines. B could own the whole COVID space when all is said and done. At the B tortoise moves forward towards the finish line as BP’s Ferraris crash and burn. PFE antiviral next.
At the latest. Any where between mid- October to end of October.
This is actually a win for B. Stopped use for hospitalized patients. That says it all. People with early CV symptoms don’t know the symptoms from allergies or the common cold. Hopefully B will help hospitalized patients. And B will move next into the mild symptom space for antivirals.
The patient target groups are not the same. B covers the tough stage, and we know if it can do well in moderate to severe, B can do mild. The mild stage would require a pill or inhaler. We would need funding to expand B’s delivery and patient mild target trial. I knew this was coming, and knew it would create a lot of angst here, even though the patient groups are different. B actually kills the virus, it will be the antiviral of choice. Can’t wait for results.
Repeat B and BPs antivirals are different target groups of patients. People posting here continue to overlap them. B’s only competition right now is Rem.
I think providing an estimated date is very responsible of Leo. No one had a clue where we were at on the results, which means a whole lot for longs. I know Merck and PFE have been given frequent updates on their antivirals, should be no difference for us. I’m just not sure why it takes us longer to get a PhII trial of 120 patients longer than Merck and PFE getting through both PHII and PIII trials. Granted EUA is given on an interim look at Merck’s antiviral.
The BP antivirals donor compete in the same space. However B can compete in any antiviral space and kill the virus , any virus. People selling not sure you know what you own. My only beef with IPIX is how long everything takes. Mid to late October now not too far off. Should add here if you can. I’m fully loaded!!!